ProCE Banner Activity

How to decide when to use different PARPi

Slideset Download

In this downloadable slideset, CCO’s expert faculty reviews different PARP inhibitors in the treatment of patients with newly diagnosed ovarian cancer.

This slideset is intended for clinicians practicing medicine outside of the United States.

Released: December 22, 2020

Expiration: December 21, 2021

No longer available for credit.

Share

Faculty

Ignace Vergote

Ignace Vergote, MD, PhD

Professor Em. of Department of Obstetrics and Gynecologic Oncology
University Hospitals Leuven Belgium

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

GlaxoSmithKline

Faculty Disclosure

Primary Author

Ignace Vergote, MD, PhD

Professor Em. of Department of Obstetrics and Gynecologic Oncology
University Hospitals Leuven Belgium